FDA Authorizes 23andMe to Report Results of Direct-to-Consumer Pharmacogenetics Test to Customers without a Prescription, Bypassing Doctors and Clinical Laboratories

FDA cautions patients to not use data gained from the DTC test to make healthcare decisions on their own Clinical laboratories continue to be impacted by the growing direct-to-consumer (DTC) testing market, as more walk-in lab customers order at-home tests. Now, the US Food and Drug Administration (FDA) has authorized a DTC test company to […]

Source: Dark Daily - January 23, 2019 Category: Laboratory Medicine Authors: Jude Tags: Coding, Billing, and Collections Compliance, Legal, and Malpractice Laboratory Hiring & Human Resources Laboratory Pathology Laboratory Testing Managed Care Contracts & Payer Reimbursement Management & Operations ACR American College of Ra Source Type: news